MedGenome Inc.
MedGenome Inc., headquartered in the United States, is a leading player in the genomics and biotechnology industry, specialising in genomic testing and research services. Founded in 2013, the company has established a strong presence in major operational regions, including India and other parts of Asia, focusing on advancing precision medicine through innovative genetic solutions. MedGenome's core offerings include comprehensive genomic testing, bioinformatics services, and research collaborations, which are distinguished by their commitment to high-quality data and actionable insights. The company has achieved significant milestones, including partnerships with renowned institutions and contributions to large-scale genomic studies, positioning itself as a trusted leader in the field. With a focus on empowering healthcare through genomics, MedGenome continues to drive advancements in personalised medicine and genetic research.
DitchCarbon Score
How does MedGenome Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MedGenome Inc.'s score of 23 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
MedGenome Inc.'s reported carbon emissions
MedGenome Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). However, the absence of data does not diminish the importance of climate commitments in the biotechnology sector. Companies in this industry are increasingly recognising the need to address climate change through sustainable practices and initiatives. MedGenome's future climate commitments and potential reduction strategies will be crucial in aligning with industry standards and contributing to global climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
MedGenome Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
